Surgical Approach to Pulmonary Metastases from Breast Cancer.

One of the main characteristics of breast cancer is its capability to disseminate. Solitary pulmonary metastases from breast cancer occur rarely (0.4%). The aim of this study is to check whether or not the outcome following the surgical treatment of pulmonary metastases in patients with breast cance...

Descripción completa

Detalles Bibliográficos
Publicado en:Breast Journal Vol. 18; no. 1; pp. 52 - 58
Autores principales: Kycler, Witold, Laski, Piotr
Formato: research tables/charts Journal Article
Publicado: Wiley-Blackwell Jan/Feb2012
Acceso en línea:Ver este registro en EBSCOhost
fields @attributes:
  recordID: 1
pdfLink:
plink: https://search.ebscohost.com/login.aspx?direct=true&db=ccm&AN=104625261&site=ehost-live
header:
  @attributes:
    shortDbName: ccm
    uiTerm: 104625261
    longDbName: CINAHL Complete
    uiTag: AN
  controlInfo:
    bkinfo:
    dissinfo:
    jinfo:
      jid:
        1075122X
        ET6
      jtl: Breast Journal
      issn: 1075122X
      maglogo: Y
    pubinfo:
      dt: Jan/Feb2012
      vid: 18
      iid: 1
      pid: 480
      pub: Wiley-Blackwell
      place: Malden, Massachusetts
    artinfo:
      ui:
        104625261
        70164820
        10.1111/j.1524-4741.2011.01176.x
        NLM22098366
        104625261
      ppf: 52
      ppct: 6
      formats:
        fmt:
          @attributes:
            type: P
      tig:
        atl: Surgical Approach to Pulmonary Metastases from Breast Cancer.
      aug:
        au:
          Kycler, Witold
          Laski, Piotr
        affil: Department of Oncological Surgery II, Great Poland Cancer Centre, Poznan, Poland
      sug:
        subj:
          Breast Neoplasms Surgery
          Neoplasm Metastasis Surgery
          Lung Neoplasms Surgery
          Treatment Outcomes Evaluation
          Human
          Female
          Retrospective Design
          Record Review
          Descriptive Statistics
          P-Value
          Survival
          Breast Neoplasms Prognosis
          Kaplan-Meier Estimator
          Cox Proportional Hazards Model
          Log-Rank Test
          Data Analysis, Statistical
          Data Analysis Software
          Adult
          Middle Age
          Aged
          Adult: 19-44 years
          Middle Aged: 45-64 years
          Aged: 65+ years
          Female
      ab: One of the main characteristics of breast cancer is its capability to disseminate. Solitary pulmonary metastases from breast cancer occur rarely (0.4%). The aim of this study is to check whether or not the outcome following the surgical treatment of pulmonary metastases in patients with breast cancer is in accordance with the data in the literature and based on it to identify prognostic factors. We have reviewed retrospectively data for 33 patients who underwent 43 curative resections of breast cancer pulmonary metastases between 1997 and 2002 at our department. Potential prognostic factors affecting survival, namely survival after lung metastasectomy, assessed were disease-free interval (DFI), the number and location of lung metastases, the diameter in mm of metastases and the extent of pulmonary resection. The median survival for 33 patients with pulmonary breast cancer metastatic lesions after metastasectomy was 73.2 months. Mean 5-year survival was 54.5%. There was a statistically significant difference in survival time with better prognosis for patients with DFI > 36 months (p = 0.0007), complete metastasectomy (p = 0.0153), unilateral pulmonary metastases (p = 0.0267) and for patients who underwent multiple operations (p = 0.0211). In multivariate analysis there was significant influence for long-term prognosis for patients with DFI > 36 months (p = 0.0446) and for complete resection of the metastases (p = 0.0275). Analysis of the survival rates for patients with solitary pulmonary metastasis, with different size of tumors and after different types of pulmonary resection showed no significant differences. It was concluded that resection of lung metastases from breast cancer may offer a significant survival benefit for selected patients. The identified prognostic factor for survival after metastasectomy is DFI longer than 36 months and complete resection of the metastases. In our group of patients, DFI longer than 36 months, unilateral pulmonary metastases and number of operations significantly influenced survival. Also, the results showed that lung metastasectomy by conventional surgery is a safe procedure with low perioperative morbidity and mortality rate.
      pubtype: Academic Journal
      doctype:
        research
        tables/charts
        Journal Article
      ougenre: Article
    language: English
    refInfo:
    holdings:
      @attributes:
        islocal: N